Bioscience company Metabolix, Inc. (MBLX) said Wednesday that it has opened its new office in Cologne, Germany.
The new office marks the first expansion for Metabolix outside of the United States and will coordinate business development, customer service and technical support to business partners and biopolymer customers based in Europe.
Located in the BioCampus Cologne life science park, the space will enable the company to directly access the European market for biopolymers and will serve as a coordination point for its regional initiatives in renewable chemicals.
According to the Freedonia Group, global demand for bioplastics is expected to more than triple through 2015, with Western Europe remaining the largest consumer of bioplastic materials. With more than 700 issued and pending patents, Metabolix has led the industry in the development of a family of biopolymers called PHAs, or polyhydroxyalkanoates.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org